Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Mitogen-Activated Protein Kinase Kinases. Found 4 abstracts

Lu H, Liu S, Zhang G, Bin W, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W. PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas. Nature. 2017 Oct 05;550(7674):133-6.   PMCID: PMC5891348
Psyrri A, Lee JW, Pectasides E, Vassilakopoulou M, Kosmidis EK, Burtness BA, Rimm DL, Wanebo HJ, Forastiere AA. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303. Clin Cancer Res. 2014 Jun;20(11):3023-32.   PMCID: Pmc4049169
Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8387-92.   PMCID: PMC2448846
Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Molecular cancer research : MCR. 2007 Jan;5(1):71-85.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Mitogen-Activated Protein Kinase Kinases

Signal Transduction metabolism Mitogen-Activated Protein Kinase Kinases genetics pharmacology Proto-Oncogene Proteins c-akt Female enzymology drug therapy physiology Tumor Cell Line Neoplasm Drug Resistance Neoplastic Gene Expression Regulation Mutation drug effects antagonists & inhibitors Phosphorylation Apoptosis Cell Proliferation Piperazines Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Estrogen Receptors beta Catenin Carboplatin Messenger RNA Fluorescent Antibody Technique Response Elements Pyrroles Platelet-Derived Growth Factor alpha Receptor Proto-Oncogene Proteins c-raf Progesterone Receptors Paclitaxel ras Proteins therapy Enzyme Activation Melanoma Genetic Transcription Proto-Oncogene Proteins B-raf Squamous Cell Carcinoma Gene Silencing Phosphatidylinositol 3-Kinases Mitogen-Activated Protein Kinases Adult Promoter Regions (Genetics) Chemoradiotherapy Gene Amplification analysis Proto-Oncogene Proteins c-kit adverse p21-Activated Kinases Monoclonal Antibodies-Humanized Middle Aged Epidermal Growth Factor Receptor MAP Kinase Signaling System TOR Serine-Threonine Kinases Male Head and Neck Neoplasms Nuclear Receptor Coactivator 2 adverse effects 1-Phosphatidylinositol 3-Kinase Estrogen Receptor alpha Estrogens effects Gastrointestinal Stromal Tumors Pyrimidines Prognosis Cultured Tumor Cells DNA Mutational Analysis Antineoplastic Agents Kaplan-Meier Estimate Electrophoretic Mobility Shift Assay Protein Kinase Inhibitors chemistry Small Interfering RNA Biological Tumor Markers Disease-Free Survival Tissue Array Analysis erbB-2 Receptor JNK Mitogen-Activated Protein Kinases Breast Neoplasms Aged IGF Type 1 Receptor Induction Chemotherapy therapeutic use mortality administration & dosage Presenilin-2 Gel Electrophoresis-Two-Dimensional Mice
Last updated on Wednesday, February 05, 2020